These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11920210)

  • 1. Acute leukemia following a previous malignancy: do acute lymphoid leukemia and acute myeloid leukemia have common risk factors?
    Pagano L; Pulsoni A; Tosti ME; Mele A; Mele L; Corvatta L; Miraglia E; Almici C; Manna A; Del Poeta G; Lanza F; Masini L; Recchia A; Equitani F; Leone G; Mandelli F;
    Hematol J; 2000; 1(5):329-32. PubMed ID: 11920210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukemia in patients previously diagnosed with breast cancer: experience of the GIMEMA group.
    Pagano L; Pulsoni A; Mele L; Tosti ME; Cerri R; Visani G; Melillo L; Candoni A; Clavio M; Nosari A; Petti MC; Martino B; Mele A; Levis A; Allione B; Almici C; Equitani F; Leone G; Mandelli F;
    Ann Oncol; 2001 Feb; 12(2):203-7. PubMed ID: 11300325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biological features of acute myeloid leukaemia occurring as second malignancy: GIMEMA archive of adult acute leukaemia.
    Pagana L; Pulsoni A; Tosti ME; Avvisati G; Mele L; Mele M; Martino B; Visani G; Cerri R; Di Bona E; Invernizzi R; Nosari A; Clavio M; Allione B; Coser P; Candoni A; Levis A; Camera A; Melillo L; Leone G; Mandelli F;
    Br J Haematol; 2001 Jan; 112(1):109-17. PubMed ID: 11225603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of secondary leukemias.
    Leone G; Mele L; Pulsoni A; Equitani F; Pagano L
    Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group.
    Lenz G; Dreyling M; Schiegnitz E; Haferlach T; Hasford J; Unterhalt M; Hiddemann W
    J Clin Oncol; 2004 Dec; 22(24):4926-33. PubMed ID: 15611507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
    Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
    Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute lymphoblastic leukaemia occurring as second malignancy: report of the GIMEMA archive of adult acute leukaemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Pagano L; Pulsoni A; Tosti ME; Annino L; Mele A; Camera A; Martino B; Guglielmi C; Cerri R; Di Bona E; Invernizzi R; Castagnola C; Bassan R; Mele L; Todeschini G; Leone G; Mandelli F
    Br J Haematol; 1999 Sep; 106(4):1037-40. PubMed ID: 10520009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
    Haase D; Hanf V; Schulz T
    Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and epidemiological features of acute lymphoblastic leukemia following a previous malignancy.
    Pagano L; Pulsoni A; Mele L; Leone G
    Leuk Lymphoma; 2000 Nov; 39(5-6):465-75. PubMed ID: 11342330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990-2005.
    Kaplan HG; Malmgren JA; Atwood MK
    BMC Cancer; 2011 Jun; 11():260. PubMed ID: 21693006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.
    Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM
    J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second malignancy following treatment of acute lymphoblastic leukemia in children.
    Kubota M; Akiyama Y; Koishi S; Sawada M; Usami I; Lin YW; Watanabe K; Takimoto T
    Int J Hematol; 1998 Jun; 67(4):397-401. PubMed ID: 9695413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
    Kröger N; Damon L; Zander AR; Wandt H; Derigs G; Ferrante P; Demirer T; Rosti G; ; ;
    Bone Marrow Transplant; 2003 Dec; 32(12):1153-7. PubMed ID: 14647269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
    Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma.
    Saso R; Kulkarni S; Mitchell P; Treleaven J; Swansbury GJ; Mehta J; Powles R; Ashley S; Kuan A; Powles T
    Br J Cancer; 2000 Jul; 83(1):91-4. PubMed ID: 10883674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy.
    Seiter K; Feldman EJ; Sreekantaiah C; Pozzuoli M; Weisberger J; Liu D; Papageorgio C; Weiss M; Kancherla R; Ahmed T
    Leukemia; 2001 Jun; 15(6):963-70. PubMed ID: 11417484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies.
    Kollmannsberger C; Hartmann JT; Kanz L; Bokemeyer C
    J Cancer Res Clin Oncol; 1998; 124(3-4):207-14. PubMed ID: 9619748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary acute myelogenous leukemia in patients previously treated for childhood renal tumors: a report from the National Wilms Tumor Study Group.
    Shearer P; Kapoor G; Beckwith JB; Takashima J; Breslow N; Green DM
    J Pediatr Hematol Oncol; 2001 Feb; 23(2):109-11. PubMed ID: 11216701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary Acute Leukemia in Sarcoma Patients: A Population-Based Study.
    Sanford NN; Martin AM; Brunner AM; Cote GM; Choy E; DeLaney TF; Aizer AA; Chen YL
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):687-694. PubMed ID: 29413281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.